CHEMOTHERAPY OF CUTANEOUS LEISHMANIASIS: LEISHMANIA TROPICA INFECTIONS IN MICE.
D000578:Amidines; D000818:Animals; D000965:Antimony; D000981:Antiprotozoal Agents; D002738:Chloroquine; D002751:Chlortetracycline; D003622:Dapsone; D003850:Deoxyribonuclease I; D004640:Emetine; D006821:Hyaluronoglucosaminidase; D039321:Hydrastis; D007895:Leishmania tropica; D007896:Leishmaniasis; D016773:Leishmaniasis, Cutaneous; D007897:Leishmaniasis, Mucocutaneous; D051379:Mice; D010336:Pathology; D010600:Pharmacology; D011319:Primaquine; D011739:Pyrimethamine; D011796:Quinacrine; D012106:Research; D013299:Streptodornase and Streptokinase; D013300:Streptokinase; D013449:Sulfonamides; D013501:Surface-Active Agents; D014116:Toxicology
D000578:Amidines; D000981:Antiprotozoal Agents; D013449:Sulfonamides; D013501:Surface-Active Agents; D002738:Chloroquine; D003622:Dapsone; D000965:Antimony; D013299:Streptodornase and Streptokinase; D003850:Deoxyribonuclease I; D006821:Hyaluronoglucosaminidase; D013300:Streptokinase; D011796:Quinacrine; D011319:Primaquine; D002751:Chlortetracycline; D004640:Emetine; D011739:Pyrimethamine
AMIDINES; ANTIMONY; ANTIPROTOZOAL AGENTS; CHLOROQUINE; CHLORTETRACYCLINE; DAPSONE; EMETINE; EXPERIMENTAL LAB STUDY; HYALURONIDASE; HYDRASTIS; LEISHMANIASIS, MUCOCUTANEOUS; MICE; PATHOLOGY; PHARMACOLOGY; PRIMAQUINE; PYRIMETHAMINE; QUINACRINE; STREPTODORNASE AND STREPTOKINASE; SULFONAMIDES; SURFACE-ACTIVE AGENTS; TOXICOLOGIC REPORT